DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR
May 23, 2023
New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious… Read More
© 2024 CSRXP- All Rights Reserved
Updates
DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING
May 12, 2023
Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While… Read More
THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS
May 12, 2023
Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On… Read More
CSRXP COMMENDS HELP COMMITTEE FOR ADVANCING BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
Senate Panel Passes Bills to Increase Competition and Increase List Price… Read More
CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and… Read More
DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES
May 9, 2023
Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN
May 9, 2023
Brand Name Drug Companies Continue to Hike Prices and Post Record Profits… Read More
CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE
May 4, 2023
Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer… Read More
BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL MYERS SQUIBB, ABBVIE AND ASTRAZENECA
May 3, 2023
More Big Pharma Giants Surpass Wall Street Expectations, Buoyed By Egregious… Read More
BIG PHARMA WATCH: BIG PHARMA SPENT $8.1 BILLION ON ADS PUSHING HIGH-PRICED BRAND NAME PRESCRIPTION DRUGS IN 2022
May 1, 2023
Big Pharma Spending Binge Underscores Bipartisan Support for List Price… Read More
DOSE OF REALITY: LIST PRICE TRANSPARENCY WILL HELP HOLD BIG PHARMA ACCOUNTABLE AND LOWER PRESCRIPTION DRUG PRICES FOR PATIENTS
Apr 25, 2023
Congress Should Advance Bipartisan, Market-Based Measures to Increase… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 24, 2023
Big Pharma Giant Kicks Off Q1 Earnings By Boasting “Strategic Price… Read More